Navigation Links
Top Industry Professional Joins Aphena as Head of Quality & Regulatory Affairs
Date:5/13/2011

COOKEVILLE, Tenn., May 13, 2011 /PRNewswire/ -- Cookeville-based Aphena Pharma Solutions Inc., a leading pharmaceutical packaging provider in the U.S., is pleased to announce that on June 1, Mary G. Foster, PharmD — one of the top regulatory professionals in the industry — will join the company as its Corp. VP of Quality and Regulatory Affairs. In this role, Foster will help Aphena to shape its vision, plan long-term goals, and further enhance the company's rigorous adherence to the highest quality and regulatory standards.

A senior-level regulatory/quality professional with more than 25 years of experience, Foster comes to Aphena from Catalent Pharma Solutions, where she served as vice president of quality. In that role, she was responsible for creating a global current Good Manufacturing Practices (cGMP) program and for training and developing connections within the industry and worldwide regulatory bodies to ensure continuous understanding and improvement of quality processes.

"We're so pleased to have Mary join the company. It is our intent to employ the industry's best and brightest, Mary certainly fits that category" said Aphena President and CEO Renard Jackson. "She shares our company's values, our focus on client expectations, and our vision for the future as a single-source industry leader."

"I've been impressed with Aphena's increasing leadership in the pharmaceutical packaging industry in recent years," said Foster. "To me, this was a logical next step in my career, and I am eager to begin working with such a quality-driven team."

Aphena was formed this year as a strategic alliance between Celeste Contract Packaging, PrePak Systems, TestPak and Integrated Pharmaceutical Packaging — all long-term specialized leaders in the contract pharma and personal care packaging, repackaging and manufacturing industry. Aphena offers turnkey solutions for the pharmaceutical, OTC, nutraceutical, animal health, health and beauty, consumer health and medical device markets.

For more information about Aphena and its subsidiaries, visit www.aphenapharma.com.


'/>"/>
SOURCE Aphena Pharma Solutions Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma Elite to Unveil Latest Industry News/Program Agenda with 70+ Expert Speakers at Exclusive Event: Pharma CI Conference, September 13-14, 2011 in New Jersey
2. OTC Industry Announces Voluntary Transition to One Concentration of Single-Ingredient Pediatric Liquid Acetaminophen Medicines
3. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
4. Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
5. Top Three Healthcare Supply Chain Executives Challenge Industry
6. Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations
7. Awarepoint to Showcase Industry-leading Real-time Location System (RTLS) at AONE Annual Meeting
8. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
9. Reportlinker Adds Global: Pharmaceuticals Industry Guide
10. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
11. FDA to Address Industry Questions About Biosimilar Regulations at the Pharmas IQ Immunogenicity Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):